Skip to main content
← Back to companies
Enlaza Therapeutics logo

Enlaza Therapeutics

61+ employeesSeries A raised

Enlaza Therapeutics is pioneering the field of covalent biologics. These novel classes of protein therapeutics deliver more efficacious and safer treatments for patients. The company’s proprietary War-Lock™ platform leverages leading synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza is building a pipeline of first-in-class covalent biologics.

Ready to start your space career at Enlaza Therapeutics?

Shipping like we're funded. We're not. No affiliation.

Sequoia logo
Y Combinator logo
Founders Fund logo
a16z logo